First Time Loading...

BRAIN Biotech AG
XETRA:BNN

Watchlist Manager
BRAIN Biotech AG Logo
BRAIN Biotech AG
XETRA:BNN
Watchlist
Price: 2.8 EUR -6.67% Market Closed
Updated: Apr 18, 2024

Profitability Summary

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Past Growth

To be successful and remain in business, both growth and profitability are important and necessary. Net Income growth is often seen as a sign of a company's efficiency from an operational standpoint, but is influenced heavily by a company's goals and challenges and should therefore be assessed in conjunction with other metrics like revenue and operating income growth.

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Earnings Waterfall
BRAIN Biotech AG

Revenue
55.2m EUR
Cost of Revenue
-24.2m EUR
Gross Profit
31m EUR
Operating Expenses
-36.7m EUR
Operating Income
-5.7m EUR
Other Expenses
-2.7m EUR
Net Income
-8.4m EUR

Margins Comparison
BRAIN Biotech AG Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
DE
BRAIN Biotech AG
XETRA:BNN
61.2m EUR
56%
-10%
-15%
JP
Shin-Etsu Chemical Co Ltd
TSE:4063
12.8T JPY
39%
30%
22%
US
Sherwin-Williams Co
NYSE:SHW
79B USD
47%
16%
10%
US
Ecolab Inc
NYSE:ECL
62.6B USD
40%
14%
9%
CH
Sika AG
SIX:SIKA
41.9B CHF
54%
15%
9%
CH
Givaudan SA
SIX:GIVN
36B CHF
41%
16%
13%
CN
Wanhua Chemical Group Co Ltd
SSE:600309
273.8B CNY
17%
12%
10%
IN
Asian Paints Ltd
NSE:ASIANPAINT
2.7T INR
43%
19%
15%
US
PPG Industries Inc
NYSE:PPG
31.8B USD
41%
12%
7%
US
Dupont De Nemours Inc
NYSE:DD
31.6B USD
35%
14%
4%
CH
DSM-Firmenich AG
AEX:DSFIR
27.1B EUR
25%
-4%
20%
Country DE
Market Cap 61.2m EUR
Gross Margin
56%
Operating Margin
-10%
Net Margin
-15%
Country JP
Market Cap 12.8T JPY
Gross Margin
39%
Operating Margin
30%
Net Margin
22%
Country US
Market Cap 79B USD
Gross Margin
47%
Operating Margin
16%
Net Margin
10%
Country US
Market Cap 62.6B USD
Gross Margin
40%
Operating Margin
14%
Net Margin
9%
Country CH
Market Cap 41.9B CHF
Gross Margin
54%
Operating Margin
15%
Net Margin
9%
Country CH
Market Cap 36B CHF
Gross Margin
41%
Operating Margin
16%
Net Margin
13%
Country CN
Market Cap 273.8B CNY
Gross Margin
17%
Operating Margin
12%
Net Margin
10%
Country IN
Market Cap 2.7T INR
Gross Margin
43%
Operating Margin
19%
Net Margin
15%
Country US
Market Cap 31.8B USD
Gross Margin
41%
Operating Margin
12%
Net Margin
7%
Country US
Market Cap 31.6B USD
Gross Margin
35%
Operating Margin
14%
Net Margin
4%
Country CH
Market Cap 27.1B EUR
Gross Margin
25%
Operating Margin
-4%
Net Margin
20%

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Return on Capital Comparison
BRAIN Biotech AG Competitors

Country Company Market Cap ROE ROA ROCE ROIC
DE
BRAIN Biotech AG
XETRA:BNN
61.2m EUR
-32%
-12%
-11%
-9%
JP
Shin-Etsu Chemical Co Ltd
TSE:4063
12.8T JPY
13%
11%
17%
17%
US
Sherwin-Williams Co
NYSE:SHW
79B USD
70%
10%
22%
14%
US
Ecolab Inc
NYSE:ECL
62.6B USD
18%
6%
12%
9%
CH
Sika AG
SIX:SIKA
41.9B CHF
20%
8%
16%
12%
CH
Givaudan SA
SIX:GIVN
36B CHF
22%
8%
12%
10%
CN
Wanhua Chemical Group Co Ltd
SSE:600309
273.8B CNY
20%
7%
17%
10%
IN
Asian Paints Ltd
NSE:ASIANPAINT
2.7T INR
35%
21%
40%
31%
US
PPG Industries Inc
NYSE:PPG
31.8B USD
18%
6%
14%
11%
US
Dupont De Nemours Inc
NYSE:DD
31.6B USD
2%
1%
5%
5%
CH
DSM-Firmenich AG
AEX:DSFIR
27.1B EUR
13%
8%
-2%
-2%
Country DE
Market Cap 61.2m EUR
ROE
-32%
ROA
-12%
ROCE
-11%
ROIC
-9%
Country JP
Market Cap 12.8T JPY
ROE
13%
ROA
11%
ROCE
17%
ROIC
17%
Country US
Market Cap 79B USD
ROE
70%
ROA
10%
ROCE
22%
ROIC
14%
Country US
Market Cap 62.6B USD
ROE
18%
ROA
6%
ROCE
12%
ROIC
9%
Country CH
Market Cap 41.9B CHF
ROE
20%
ROA
8%
ROCE
16%
ROIC
12%
Country CH
Market Cap 36B CHF
ROE
22%
ROA
8%
ROCE
12%
ROIC
10%
Country CN
Market Cap 273.8B CNY
ROE
20%
ROA
7%
ROCE
17%
ROIC
10%
Country IN
Market Cap 2.7T INR
ROE
35%
ROA
21%
ROCE
40%
ROIC
31%
Country US
Market Cap 31.8B USD
ROE
18%
ROA
6%
ROCE
14%
ROIC
11%
Country US
Market Cap 31.6B USD
ROE
2%
ROA
1%
ROCE
5%
ROIC
5%
Country CH
Market Cap 27.1B EUR
ROE
13%
ROA
8%
ROCE
-2%
ROIC
-2%

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

See Also

Discover More